We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

76 hedge funds and large institutions have $49.8M invested in Lineage Cell Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,600% more call options, than puts

Call options by funds: $67K | Put options by funds: $1K

3% more capital invested

Capital invested by funds: $48.5M → $49.8M (+$1.37M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

1.45% less ownership

Funds ownership: 37.18%35.73% (-1.4%)

19% less funds holding

Funds holding: 9476 (-18)

46% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 24

90% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 20

Holders
76
Holders Change
-18
Holders Change %
-19.15%
% of All Funds
1.53%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
2
Increased
13
Reduced
24
Closed
20
Calls
$67K
Puts
$1K
Net Calls
+$66K
Net Calls Change
-$30K
Name Holding Trade Value Shares
Change
Change in
Stake
RIM
76
Regent Investment Management
Kentucky
-$17K -20,000 Closed
GCP
77
GSA Capital Partners
United Kingdom
-$13K -15,191 Closed
ARTA
78
A.R.T. Advisors
New York
-$11K -12,825 Closed
LCM
79
Laurion Capital Management
New York
-$11K -12,476 Closed
RAM
80
Riggs Asset Management
Pennsylvania
-$10K -11,600 Closed
KMWM
81
Keudell/Morrison Wealth Management
Oregon
-$9K -10,105 Closed
Cerity Partners
82
Cerity Partners
New York
-$9K -10,000 Closed
EWM
83
Edge Wealth Management
New York
-$3K -4,000 Closed
CAN
84
Cetera Advisor Networks
California
-$1K -665 Closed